远大控股：12月5日召开董事会会议

Group 1 - The core point of the article is that Yuanda Holdings announced a board meeting to discuss the acquisition of approximately 14.88% equity in its subsidiary Fujian Kaili Biological Products Co., Ltd. [1] - The meeting was held electronically on December 5, 2025, and included the review of relevant documents regarding the acquisition [1]. - As of the report, Yuanda Holdings has a market capitalization of 4.1 billion yuan [1]. Group 2 - For the first half of 2025, Yuanda Holdings' revenue composition was as follows: 99.36% from commodity trading, 0.35% from biological agriculture, 0.26% from special oil processing, and 0.02% from logistics agency services [1].